TAL Cannabis Investment Report | December 2017
Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.
View the original on the official releaseDocument text
Text is machine OCR and may contain errors. Confirm against the original source above.
A
>
KR
I
P
ELL
TAL Cannabis Investment Report | December 2017
w U.S. State Law
Of the 51 jurisdictions comprising the 50 U.S. states and the District of Columbia, 47 have enacted
at least one law that permits the manufacturing, distribution, dispensing or possession of cannabis or
concentrates. These laws fall into three general categories:
¢ 29 USS. states and the District of Columbia have enacted medical cannabis laws that permit
the production and possession of cannabis or concentrates for use in treating a broad range of
qualifying medical conditions,
° 19 U.S. states have enacted narrow CBD/limited laws that permit possession of small amounts
of low-THC/high-CBD cannabis concentrates for use in treating a few serious medical condi-
tions—in particular, severe forms of childhood epilepsy.
° 8 USS. states have enacted recreational laws that permit the commercial production and sale of
cannabis to adults for recreational and other uses.
Some states have passed more than one of these laws, and some state laws do not fall clearly into
any one of these categories. Florida and Delaware have both medical cannabis and CBD/limited laws.
Every state that has enacted a recreational law has also passed a medical cannabis law. A District of
Columbia law that permits adults to grow and consume cannabis is often cited as a recreational law;
however, we do not characterize it as such because it does not permit the commercial production and
sale of cannabis. The following map of the United States shows states with medical cannabis laws,
CBD /limited laws or recreational laws (a state with more than one of these laws is represented on the
map by its most permissive law).
62 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC
HOUSE_OVERSIGHT_024698
Have a question about what this document contains?
Ask the documents